Noninvasive respiratory support in hypoxic respiratory failure: stay safe and know your limits

Symposium
Chairs: M. Duiverman (Groningen, Netherlands), J. Winck Fernandes Cruz (Vila Nova de Gaia, Portugal)
Aims: To will discuss the assessment of the acute hypoxic respiratory failure; to outline the risks vs benefits of non-invasive ventilation (NIV) support for COVID patients; to explain the role of NIV in the management of refractory dyspnoea; and to discuss the physiological changes during continuous positive airway pressure (CPAP), NIV and High-flow nasal cannula (HFNC).
How to assess the severity of acute hypoxic respiratory failure
L. Camporota (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Noninvasive respiratory support during Covid 19: risks and benefits
S. Nava (Bologna (BO), Italy)
WebcastSlide presentation
WebcastSlide presentation
Management of refractory dyspnoea in end-stage patients: the use of noninvasive respiratory support
M. Duiverman (Groningen, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
Physiological changes during CPAP, NIV and HFNC: one for all or all for one ?
M. Vega (Bologba, Italy)
WebcastSlide presentation
WebcastSlide presentation
Discussion and Q&A

Webcast
Webcast